RESUMO
INTRODUCTION: Available studies have shown the involvement of nitric oxide (NO) in the processes that lead to neurodegeneration in Parkinson's disease (PD). Also, the use of inhibitors of the inducible isoform of NO-synthase (iNOS) promotes neuroprotection and attenuates dopamine (DA) loss in experimental models of Parkinsonism. In addition, NO also appears to be involved in cardiovascular changes in 6-hydroxydopamine (6-OHDA)-induced Parkinsonism. The current study aimed to evaluate the effects of iNOS inhibition on cardiovascular and autonomic function in animals that were subjected to Parkinsonism by the administration of 6-OHDA. MATERIALS AND METHODS: The animals underwent stereotaxic surgery for bilateral microinfusion of the neurotoxin 6-OHDA (6 mg/mL in 0.2% ascorbic acid in sterile saline solution) or vehicle solution for the Sham group. From the day of stereotaxis until the day of femoral artery catheterization, the animals were treated with the iNOS inhibitor, S-methylisothiourea (SMT; 10 mg/kg; i. p.) or saline solution (0.9%; i. p.) for 7 days. The animals were divided into four groups: Sham-Saline, Sham-SMT, 6-OHDA-Saline, and 6-OHDA-SMT. Subsequent analyses were performed on these four groups. After 6 days, they underwent catheterization of the femoral artery, and 24 h later, mean arterial pressure (MAP) and heart rate (HR) were recorded. Another group of animals (the 6-OHDA and Sham groups) was assessed for aortic vascular reactivity after 7 days of bilateral infusion of 6-OHDA or vehicle, in which cumulative concentration-effect curves (CCEC) were made for phenylephrine (Phenyl), acetylcholine and sodium nitroprusside (NPS). Also, CCEC in the presence of Nw-nitro-arginine-methyl-ester (l-NAME) (10-5 M), SMT (10-6 M), and indomethacin (10-5 M) blockers were made. RESULTS: The effectiveness of the 6-OHDA lesion was confirmed with the reduction of DA in 6-OHDA animals. However, treatment with SMT could not reverse the loss of DA. Concerning the baseline parameters, SBP and MAP values were lower in 6-OHDA animals compared to their Sham control, with no effect of treatment with SMT. In the analysis of SBP variability, a decrease in variance, the VLFabs component, and the LFabs component were observed in the 6-OHDA groups when compared to their controls, regardless of treatment with SMT. It was also observed that intravenous injections of SMT resulted in an increase in BP and a decrease in HR. However, the response was not different between the Sham and 6-OHDA groups. In vascular function, there was a hyporeactivity to Phenyl in the 6-OHDA group, and when investigating the mechanisms of this hyporeactivity, it was seen that the Rmax to Phenyl increased with incubation with SMT, indicating that iNOS could be involved in the vascular hyporeactivity of animals with Parkinsonism. CONCLUSION: Thus, the set of results presented in this study suggests that part of the cardiovascular dysfunction in animals subjected to 6-OHDA Parkinsonism may be peripheral and involve the participation of endothelial iNOS.
Assuntos
Sistema Cardiovascular , Transtornos Parkinsonianos , Animais , Masculino , Ratos , Dopamina , Inibidores Enzimáticos/farmacologia , NG-Nitroarginina Metil Éster/farmacologia , Oxidopamina/farmacologia , Transtornos Parkinsonianos/induzido quimicamente , Transtornos Parkinsonianos/tratamento farmacológico , Fenilefrina , Ratos Wistar , Solução SalinaRESUMO
AIM: The present study evaluated whether topiramate (TPM) treatment during the peripubertal period affects vascular parameters of male rats and whether oxidative stress plays a role in these changes. MAIN METHODS: Rats were treated with TPM (41 mg/kg/day, gavage) or vehicle (CTR group) from the postnatal day (PND) 28 to 50. At PND 51 and 120 the rats were evaluated for: thoracic aorta reactivity to phenylephrine, in the presence (Endo+) or absence of endothelium (Endo-), to acetylcholine and to sodium nitroprusside (SNP), aortic thickness and endothelial nitric oxide synthase (eNOS) expression. In serum were analyzed: the antioxidant capacity by ferric reducing antioxidant power assay; endogenous antioxidant reduced glutathione, and superoxide anion. Results were expressed as mean ± s.e.m., differences when p < 0.05. STATISTICS: Two-way ANOVA (and Tukey's) or Student t-test. KEY FINDINGS: At PND 51, the contraction induced by phenylephrine in Endo+ ring was higher in TPM when compared to CTR. At PND 120, the aortic sensitivity to acetylcholine in TPM rats was reduced in comparison with CTR. The aortic eNOs expression and the aortic thickness were similar between the groups. At PND 51 and 120, TPM group presented a decrease in antioxidants when compared to CTR groups and at PND 120, in TPM group the superoxide anion was increased. SIGNIFICANCE: Taken together, the treatment of rats with TPM during peripubertal period promoted permanent impairment of endothelial function probably mediated by oxidative stress.
Assuntos
Acetilcolina , Antioxidantes , Ratos , Animais , Masculino , Antioxidantes/farmacologia , Antioxidantes/metabolismo , Topiramato/farmacologia , Acetilcolina/metabolismo , Superóxidos/metabolismo , Endotélio Vascular/metabolismo , Óxido Nítrico Sintase Tipo III/metabolismo , Estresse Oxidativo , Aorta Torácica/metabolismo , Fenilefrina/farmacologia , Óxido Nítrico/metabolismoRESUMO
Topiramate (TOP) is a psychotropic drug prescribed for the treatment of epilepsy in children older than 2 years of age and for migraine prophylaxis in adolescents. There is evidence that TOP promotes negative effects on the reproductive system of male rats. This study aimed to evaluate the immediate and late treatment effects of TOP during childhood and adolescence on the male rat reproductive system. Two experimental groups received 41 mg/kg of TOP daily, by gavage, from postnatal day (PND) 16 to 28 (TOPc group) or from PND 28 to 50 (TOPa group). Control groups (CTRc group or CTRa group) received water daily. Half of the anim-als were evaluated 24 h after the end of treatment (PND 29 and PND 51, respectively) and the remainder were evaluated in adulthood (PND120). The following parameters were determined: anogenital distance, sperm evaluation, testis' histomorphometry and plasma testosterone concentration. At PND 120, the volume (CTRc:62.58 ± 2.13; TOPc: 54.54 ± 2.10*%, p = 0.018) and total length (CTRc: 25.48 ± 1.61; TOPc: 18.94 ± 2.41*, p = 0.035) of seminiferous tubules were decreased and the volume of interstitial tissue (CTRc:37.41 ± 2.13; TOPc: 45.45 ± 2.09*%, p = 0.018) and number of Leydig cells/testis (CTRc: 277.00 ± 36.70; TOPc: 400.20 ± 13.23*, p = 0.013) were increased in the TOPc group. The other parameters remained similar between the groups. Therefore, the present study contributes to our understanding that childhood treatment with TOP has an impact on the rat reproductive system in adulthood, suggesting that this period is more sensitive to TOP exposure than adolescence.
Assuntos
Sêmen , Testículo , Masculino , Animais , Ratos , Topiramato , Espermatozoides , Testosterona , Progressão da DoençaRESUMO
AIMS: This study aimed to evaluate the short- and long-term adverse effects of blood pressure (BP), vascular endothelial function, and estrogen receptor (ERα and ERß) modulation on endothelial function in female Wistar rats treated with topiramate (TPM), an antiepileptic drug, during the peripubertal period. MATERIALS AND METHODS: Female Wistar rats were treated with TPM (41 mg/kg) or water (CTR group) by gavage from postnatal day (PND) 28 to 50 (peripubertal phase). At the end of the treatment, the TPM and CTR rats were divided into two groups and evaluated after 24 h or from PND 85 (adulthood). The rats were evaluated for: thoracic aorta reactivity to phenylephrine (Phenyl), acetylcholine (ACh), and sodium nitroprusside (SNP); aortic ring reactivity after ERα and ERß antagonism; and BP. KEY FINDINGS: It was observed that vascular response to Phenyl, ACh, and SNP was similar between TPM and CTR rats in the short- and long-term evaluations. In addition, the ER antagonism did not interfere with aortic contraction or relaxation in either TPM or CTR. SIGNIFICANCE: Taken together, the results show that TPM treatment during the peripubertal period does not alter aortic endothelial function and its estrogen modulation via classic ER in female Wistar rats, suggesting that TPM treatment in this period is safe for the vascular system.
Assuntos
Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Ratos , Feminino , Animais , Ratos Wistar , Topiramato/farmacologia , Vasoconstrição , Nitroprussiato/farmacologia , Fenilefrina/farmacologia , Receptores de Estrogênio , Acetilcolina/farmacologia , Endotélio VascularRESUMO
Protein restriction during early phases of body development, such as intrauterine life can favor the development of vascular disorders. However, it is not known if peripubertal protein restriction can favor vascular dysfunction in adulthood. The present study aimed to evaluated whether a protein restriction diet during peripubertal period favors endothelial dysfunction in adulthood. Male Wistar rats from postnatal day (PND) 30 until 60 received a diet with either 23% protein (CTR group) or with 4% protein (LP group). At PND 120, the thoracic aorta reactivity to phenylephrine, acetylcholine, and sodium nitroprusside was evaluated in the presence or absence of: endothelium, indomethacin, apocynin and tempol. The maximum response (Rmax) and pD2 (-log of the concentration of the drug that causes 50% of the Rmax) were calculated. The lipid peroxidation and catalase activity were also evaluated in the aorta. The data were analyzed by ANOVA (one or two-ways and Tukey's) or independent t-test; the results were expressed as mean ± S.E.M., p < 0.05. The Rmax to phenylephrine in aortic rings with endothelium were increased in LP rats when compared with the Rmax in CTR rats. Apocynin and tempol reduced Rmax to phenylephrine in LP aortic rings but not in CTR. The aortic response to the vasodilators was similar between the groups. Aortic catalase activity was lower and lipid peroxidation was greater in LP compared to CTR rats. Therefore, protein restriction during the peripubertal period causes endothelial dysfunction in adulthood through a mechanism related to oxidative stress.
RESUMO
Paracetamol (PAR) is an over-the-counter medicine used as analgesic or antipyretic by 40-50% of the pregnant women in different countries. Epidemiologic studies have been associating maternal use of PAR with neurodevelopmental disruption and special attention has been given to its potential to increase the odds for neurodevelopmental disorders, such as attention-deficit hyperactive disorder and autism spectrum disorder. Population-based research do not allow the establishment of causal relationships because variable control is weak. We aimed to evaluate the potential of PAR to induce developmental neurotoxicity in rats. Pregnant Wistar rats were gavaged with PAR (350â¯mg/kg/day) or water from gestational day 6 until delivery. General toxicity endpoints included dams' body weight and food intake as well as pups' body weight until weaning. Behavioral evaluation occurred at post-natal days 10 (nest seeking test), 27 (behavioral stereotypy), 28 (three chamber sociability test and open field) and 29 (hot plate and elevated plus-maze). Moreover, lipid hidroperoxide (LOOH), reduced glutathione (GSH) and brain derived neurotrophic factor (BDNF) levels were quantified in prefrontal cortex and hippocampus of 22-days-old rats. Gestational exposure to PAR impaired nest seeking behavior, augmented apomorphine-induced behavioral stereotypy and decreased rostral grooming in the elevated plus maze. Exposed female pups presented elevated vertical exploration in the open field test. No alterations were observed in LOOH, GSH or BDNF levels in the prefrontal cortex or hippocampus. Exposure regimen did not affect general toxicity parameters or pups' behavior in the hot plate and sociability tests. These data suggest PAR as a developmental neurotoxicant. Observed alterations may be relevant for neurodevelopmental disorders.
Assuntos
Acetaminofen/efeitos adversos , Apomorfina/farmacologia , Comportamento Exploratório/efeitos dos fármacos , Asseio Animal/efeitos dos fármacos , Comportamento de Nidação/efeitos dos fármacos , Efeitos Tardios da Exposição Pré-Natal/psicologia , Comportamento Estereotipado/efeitos dos fármacos , Animais , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Sinergismo Farmacológico , Feminino , Glutationa/metabolismo , Hipocampo/metabolismo , Peróxidos Lipídicos/metabolismo , Masculino , Estresse Oxidativo/efeitos dos fármacos , Córtex Pré-Frontal/metabolismo , Gravidez , Efeitos Tardios da Exposição Pré-Natal/induzido quimicamente , Efeitos Tardios da Exposição Pré-Natal/metabolismo , RatosRESUMO
RESUMO Os hormônios sexuais femininos como estrogênio e progesterona têm relação com receptores específicos localizados em regiões cerebrais e podem influenciar o controle motor. Analisou-se o desempenho funcional nas diversas fases do ciclo menstrual em mulheres jovens e saudáveis. O estudo caracteriza-se como transversal e incluiu 13 mulheres saudáveis com ciclo menstrual regular e que não faziam uso de contraceptivo oral. Para a avaliação do desempenho funcional foram utilizados os testes Side Hop Test (SHT), Figure of Eight Hop Test (F8T) e Modified Star Excursion Balance Test (mSEBT) aplicados em três fases do ciclo menstrual (menstrual, ovulatória e lútea). Este estudo estabeleceu diferença significativa para os testes funcionais SHT e F8T entre as fases do ciclo menstrual, com piores resultados para a fase menstrual. O mSEBT não estabeleceu qualquer diferença. Concluiu-se que o desempenho funcional nos testes SHT e F8T foi significativamente pior na fase menstrual, quando comparado à ovulatória e lútea. Estes resultados podem ser considerados para avaliação e prescrição de condutas fisioterapêuticas para mulheres na fase menstrual, já que seu desempenho funcional pode estar comprometido.
RESUMEN Las hormonas sexuales femeninas como estrógeno y progesterona tienen relación con receptores específicos localizados en regiones cerebrales y pueden influenciar el control motor. Se analizó el rendimiento funcional en las diversas fases del ciclo menstrual en mujeres jóvenes y sanas. El estudio se caracterizó como transversal e incluyó a 13 mujeres sanas con ciclo menstrual regular y que no utilizaban anticonceptivo oral. Para la evaluación del rendimiento funcional se utilizaron las pruebas Side Hop Test (SHT), Figure of Eight Hop Test (F8T) y Modified Star Excursion Balance Test (mSEBT) aplicados en tres fases del ciclo menstrual (menstrual, ovulatoria y lútea). Este estudio estableció una diferencia significativa para las pruebas funcionales SHT y F8T entre las fases del ciclo menstrual, con peores resultados para la fase menstrual. El mSEBT no estableció ninguna diferencia. Se concluyó que el desempeño funcional en las pruebas SHT y F8T ha sido significativamente peor en la fase menstrual comparándose a la ovulatoria y lútea. Estos resultados pueden ser considerados para evaluación y prescripción de conductas fisioterapéuticas para mujeres en la fase menstrual, ya que su rendimiento funcional puede estar comprometido.
ABSTRACT Female sex hormones as estrogen and progesterone are related to specific receptors located in brain regions and can influence on motor control. We analyzed the functional performance in several menstrual cycle phases in healthy and young women. The study is characterized as cross-sectional, it included 13 healthy women with regular menstrual cycle and who were not using oral contraceptive. To assess the functional performance, we used Side Hop Test (SHT), Figure of Eight Hop Test (F8T) and Modified Star Excursion Balance Test (mSEBT) applied in three phases of the menstrual cycle (menstrual, ovulation and luteal). This study established significant difference to functional tests SHT and F8T between menstrual cycle phases, with worse results for the menstrual phase. The mSEBT established no difference. We concluded that the functional performance in tests SHT and F8T was significantly worse on menstrual phase, when compared to the ovulation and luteal phases. These results can be considered for assessment and prescription of physical therapeutic conducts for women in menstrual phase, since their functional performance can be impaired.